Carregant...
A checklist for managed access programmes for reimbursement co‐designed by Canadian patients and caregivers
INTRODUCTION: Reimbursement decisions on orphan drugs carry significant uncertainty, and as the amount increases, so does the risk of making a wrong decision, where harms outweigh benefits. Consequently, patients often face limited access to orphan drugs. Managed access programmes (MAPs) are a mecha...
Guardat en:
| Publicat a: | Health Expect |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6250858/ https://ncbi.nlm.nih.gov/pubmed/29624799 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/hex.12690 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|